CpG oligodeoxynucleotides as vaccine adjuvants in primates

D Verthelyi, RT Kenney, RA Seder, AA Gam… - The journal of …, 2002 - journals.aai.org
D Verthelyi, RT Kenney, RA Seder, AA Gam, B Friedag, DM Klinman
The journal of immunology, 2002journals.aai.org
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune
adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG
ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal
models are needed to monitor the activity and safety of “human” CpG ODN in vivo. This work
demonstrates that rhesus macaques recognize and respond to the same CpG motifs that
trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania …
Abstract
Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal models are needed to monitor the activity and safety of “human” CpG ODN in vivo. This work demonstrates that rhesus macaques recognize and respond to the same CpG motifs that trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania vaccine provided significantly increased protection of macaques against cutaneous Leishmania infection. These findings indicate that rhesus macaques provide a useful model for studying the in vivo activity of human CpG motifs, and that ODN expressing these motifs act as strong immune adjuvants.
journals.aai.org